Pharma

New Delhi | May 24, 2013 13:44 (IST)

The company's step down subsidiary, will receive 2.347 Australian dollars per Dental Corporation share aggregating to 270.38 million Australian dollars, it added.

Hyderabad | May 23, 2013 22:56 (IST)

Glenmark Generics, a subsidiary of Glenmark Pharmaceuticals, is recalling multiple lots of three of its drugs from the US market due to "odd smell", according to US Food and Drug Administration.

May 15, 2013 18:06 (IST)

Shareholders of South Africa's Cipla Medpro overwhelmingly approved a $488 million takeover offer from India's Cipla Ltd on Wednesday, giving the Indian drugmaker a big presence in Africa's biggest economy.

May 14, 2013 16:07 (IST)

The company had posted a net profit of Rs 342.70 crore for the corresponding quarter previous fiscal, the company said in a statement.

May 08, 2013 18:02 (IST)

India's top drugmakers, among the world's biggest producers of cheap generic medicines, are looking beyond their own shores to generate revenue, seeking to profit from big-selling drugs going off-patent this year in the lucrative U.S. market.

New Delhi | May 08, 2013 14:37 (IST)

Net sales of the company rose to Rs 2,537.4 crore for the January-March quarter, compared to Rs 1,883.2 crore in the same period of previous fiscal, Lupin Ltd said in a statement.

New Delhi | May 07, 2013 14:30 (IST)

Net sales of the company for the quarter under consideration also rose to Rs 632.14 crore from Rs 622.78 crore for the same period year ago.

May 06, 2013 12:24 (IST)

StarMine's SmartEstimates, which places greater emphasis on forecasts by top-rated analysts, shows Glenmark could report a net profit of Rs 156 crore for the quarter, compared with a mean consensus estimate of Rs 168 crore.

April 28, 2013 12:31 (IST)

Biotechnology major Biocon plans to launch in July its novel biologic drug Itolizumab branded as 'Alzumab' to be used for the treatment of chronic plaque psoriasis in the country.

April 24, 2013 08:35 (IST)

U.S. Attorney Preet Bharara in Manhattan said Novartis had since 2005 induced at least 20 pharmacies to switch thousands of kidney transplant patients to its immunosuppressant drug Myfortic from competitors' drugs, in exchange for kickbacks disguised as rebates and discounts.

New Delhi | April 12, 2013 13:45 (IST)

The American drug major is involved in a patent row with Glenmark which has recently come out with the two medicines in alleged violation of intellectual property rights (IPR) used in its drugs Januvia and Janumet.

New Delhi | April 10, 2013 14:07 (IST)

The Delhi High Court today posted April 12 as the date of hearing for an appeal filed by US pharmaceuticals major Merck Sharp and Dohme (MSD) against the single judge bench order refusing to restrain Indian firm Glenmark from manufacturing and selling anti-diabetes drugs Zita and Zita-Met.

Geneva | April 08, 2013 23:47 (IST)

Commerce and Industry Minister Anand Sharma said India would revoke drug patents if outbreaks of serious diseases or pandemics made it necessary, defending a Supreme Court ruling against Swiss drug firm Novartis.

New Delhi | April 05, 2013 16:13 (IST)

Justice Rajiv Sahai Endlaw dismissed the interim application of the multinational pharma major that the Mumbai-based firm be restrained from manufacturing and selling the anti-diabetes medicines on the grounds that the salt used in the drugs were not of generic nature.

New Delhi | April 04, 2013 13:12 (IST)

Drug firm Dr Reddy's Laboratories today said it has launched generic Zoledronic Acid injection used for treating osteoporosis and Paget's disease of bone in the US market following approval from the US health regulator.

New Delhi | April 03, 2013 13:28 (IST)

Drug firm Aurobindo Pharma today said it has received tentative approval from the US health regulator to manufacture and market its anti-AIDS combination drug Efavirenz/Emtricitabine and Tenofovir Disoproxil Fumarate tablets in the American market.

Washington, United States | April 03, 2013 08:15 (IST)

"Innovation requires the reward and protection of intellectual property. We are certain India's leadership understands this, and that creating and maintaining an environment that inspires and enables innovation is in India's ultimate, long-term interest. Such an environment is crucial if India is to attract investment in this or other highly complex sectors," US-India Business Council president Ron Somers said.

Washington, United States | April 03, 2013 08:02 (IST)

"We are ... reviewing the Court's order. We look forward to continued engagement and successful collaboration with India on these issues," said Andrea Mead, a spokeswoman for the US Trade Representative's office.

New Delhi | April 01, 2013 14:21 (IST)

The Supreme Court today rejected Swiss drugmaker Novartis AG's plea for a patent protection of its cancer drug Glivec, a move likely to boost the prospects of Indian pharmaceutical firms over foreign ones.

April 01, 2013 10:48 (IST)

The Supreme Court has dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales.